 | | PRD_000750 | | Name: | CYCLIC KNOTTIN TRYPSIN INHIBITOR II | | Formula: | C138 H229 N47 O45 S6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000752 | | Name: | CIRCULIN A | | Formula: | C134 H211 N38 O38 S6 | | Definition date: | 2020-08-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000754 | | Name: | PSEUDO-IODOTYROSTATIN | | Formula: | C23 H27 I N2 O4 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000755 | | Name: | BOC ALA ALA PRO PVA | | Formula: | C20 H37 N4 O8 P | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000756 | | Name: | N-(3-carboxypropanoyl)-L-valyl-N-[(1R)-5-amino-1-phosphonopentyl]-L-prolinamide | | Formula: | C19 H35 N4 O8 P | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000758 | | Name: | THIOPEPTIDE THIOSTREPTON REDUCED AT N-CA BOND OF RESIDUE 14 | | Formula: | C72 H86 N19 O18 S5 | | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES, ONE THIOZOLINE,
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE, RESIDUE 0, IS LINKED TO
MAIN-CHAIN RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 14 WAS CHEMICALLY MODIFIED TO
HAVE A SINGLE BOND N-CA. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000759 | | Name: | THIOPEPTIDE THIOSTREPTON WITH EPIMER FORM OF RESIDUE 9 | | Formula: | C69 H81 N18 O17 S5 | | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES ONE THIOZOLINE
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE, RESIDUE 0, IS LINKED TO
MAIN-CHAIN RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 9 WAS CHEMICALLY MODIFIED
FROM D-CYS TO L-CYS AND RESIDUE 17 (HET DHA)
WAS DELETED. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000760 | | Name: | THIOPEPTIDE THIOSTREPTON OXIDIZED AT CA-CB BOND OF RESIDUE 9 | | Formula: | C69 H79 N18 O17 S5 | | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES ONE THIOZOLINE
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE LINKED TO MAIN-CHAIN
RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 9 WAS CHEMICALLY MODIFIED: THE
CA-CB BOND WAS OXIDIZED FROM SINGLE TO DOUBLE.
RESIDUE 17 (HET DHA) WAS DELETED. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000762 | | Name: | METHANOBACTIN MB-OB3B | | Formula: | C45 H56 Cu N10 O16 S5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000764 | | Name: | CYCLOSPORIN D, 5,7 mutation | | Formula: | C64 H117 N11 O12 S | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED IN DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL).
THE CYCLOSPORIN D MOLECULE WAS MODIFIED AT
POSITIONS 5 AND 7 TO BE
(6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N-DIMETHYL-THREONINE AND
(2-S-METHYL)-SARCOSINE, RESPECTIVELY. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000765 | | Name: | CYCLOSPORIN A, 5 mutation | | Formula: | C63 H113 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN WAS MODIFIED AT POSITION 5 TO BE
4-[(E)-2-BUTENYL]-4,4,N-TRIMETHYL-L-THREONINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000766 | | Name: | CYCLOSPORIN A, 6 mutation | | Formula: | C63 H113 N11 O13 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 6 TO BE 2-AMINO-5-HYDROXYPENTANOIC ACID | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000767 | | Name: | CYCLOSPORIN A, 7 mutation | | Formula: | C63 H113 N11 O13 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A WAS MODIFIED AT POSITION 7
TO BE N-METHYL-D-SERINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000768 | | Name: | CYCLOSPORIN A, 8 mutation | | Formula: | C62 H111 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 8 TO BE N-METHYL-ISOLEUCINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000769 | | Name: | 2-{(3S)-3-[(benzylsulfonyl)amino]-2-oxopiperidin-1-yl}-N-{(2S)-1-[(3S)-1-carbamimidoylpiperidin-3-yl]-3-oxopropan-2-yl}acetamide | | Formula: | C23 H34 N6 O5 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_002426 | | Name: | Corramycin | | Formula: | C51 H81 N11 O21 | | Definition date: | 2023-08-16 | | Last modified: | 2023-08-16 |
|
 | | PRD_002432 | | Name: | Pam3-SKKKK | | Formula: | C81 H160 N10 O13 S | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-12 |
|
 | | PRD_002528 | | Name: | 142D6 | | Formula: | C26 H37 F N4 O6 S | | Description: | Lys-covalent pan-IAP inhibitor | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-12 |
|
 | | PRD_002527 | | Name: | Intermediate for maxamycins synthesis | | Formula: | C84 H114 Cl2 N8 O17 S Si2 | | Definition date: | 2023-07-05 | | Last modified: | 2023-07-05 |
|
 | | PRD_002431 | | Name: | Cyclic tetraadenosine monophosphate (cA4) | | Formula: | C40 H48 N20 O24 P4 | | Description: | Cyclic oligoadenylates such as c-tetraAMP were found to be novel bacterial second messengers. Antiviral in context of signalling for Type III CRISPR-Cas systems. | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-03 |
|
 | | PRD_002484 | | Name: | [(2R,3R,4S,5S,6R)-6-(hydroxymethyl)-2,4,5-tris(oxidanyl)oxan-3-yl]oxy-N-[9-[(2R,3S,5R)-5-[[[(2R,3S)-4-methyl-2,3-bis(oxidanyl)pentanoyl]amino]-oxidanyl-phosphoryl]oxy-3-oxidanyl-oxolan-2-yl]purin-6-yl]phosphonamidic acid | | Formula: | C21 H34 N6 O16 P2 | | Description: | unusual glycan purine conjugate (containing BGC and ADE) | | Definition date: | 2023-06-14 | | Last modified: | 2023-06-14 |
|
 | | PRD_001065 | | Name: | teicoplanin | | Formula: | C88 H97 Cl2 N9 O34 | | Definition date: | 2013-05-29 | | Last modified: | 2023-06-11 |
|
 | | PRD_002099 | | Name: | Uridine 5'Diphospho N-acetyl muramoyl-L-Alanyl-D-Glutamyl-L-Lysine | | Formula: | C34 H55 N7 O24 P2 | | Definition date: | 2013-10-02 | | Last modified: | 2023-06-11 |
|
 | | PRD_002268 | | Name: | Lipid II | | Formula: | C54 H91 N8 O26 P2 | | Definition date: | 2020-08-19 | | Last modified: | 2023-06-11 |
|
 | | PRD_002330 | | Name: | Darobactin | | Formula: | C47 H56 N11 O12 | | Definition date: | 2021-04-21 | | Last modified: | 2023-06-11 |
|
